Closed
SectorHealthcare
556.3 -0.37
24h
Min
554.37
Max
562.13
Income | 583M 1.4B |
---|---|
Sales | 647M 3.7B |
P/E Sector Avg | 14.063 35.733 |
EPS | 8.22 |
Dividend yield | 0.31 |
Profit margin | 37.86 |
Employees | 15,182 |
EBITDA | 617M 1.7B |
Recommendations | Buy |
---|---|
12 Months Forecast | +32.5% upside |
Dividend yield Sector Avg | 0.31% 3.13% |
---|---|
Next Earnings | 30 paź 2025 |
Market Cap | -1.1B 59B |
---|---|
Previous open | 556.67 |
Previous close | 556.3 |
By Acuity
40%
60%
122 / 371 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 739.95 USD 32.5%
High 890 USD
Low 543 USD
Based on 22 Wall Street analysts offering 12 month price targets forRegeneron Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$